articleIn this exclusive interview, Dr Hank Mansbach, Chief Medical Officer…
24 March 2023 | By Catherine Eckford (European Pharmaceutical Review), Dr Hank Mansbach (89bio)
In this exclusive interview, Dr Hank Mansbach, Chief Medical Officer of 89bio discusses clinical development of FGF21 therapy to treat fatty liver disease.